Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Hyperfine, Inc. Director's Dealing 2022

Nov 29, 2022

34088_dirs_2022-11-29_4d7e52c4-6b7e-48f2-975f-9041a22bd508.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Hyperfine, Inc. (HYPR)
CIK: 0001833769
Period of Report: 2022-11-29

Reporting Person: ROTHBERG JONATHAN M (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-11-29 Class A Common Stock P 47007 $0.72 Acquired 656492 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Class A Common Stock 585737 Indirect
Class A Common Stock 440295 Indirect
Class A Common Stock 95507 Indirect
Class B Common Stock 6867790 Indirect
Class B Common Stock 818750 Indirect
Class B Common Stock 1842187 Indirect
Class B Common Stock 1842187 Indirect
Class B Common Stock 1842187 Indirect
Class B Common Stock 1842187 Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.69 to $0.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth above.

F2: Dr. Rothberg is the sole manager of 4C Holdings I, LLC, 4C Holdings V, LLC, 2012 JMR Trust Common, LLC, JNR TR, LLC, GBR TR, LLC, NVR TR, LLC and EJR TR, LLC. Dr. Rothberg is the spouse of Bonnie E. Gould Rothberg MD and Dr. Rothberg's son is the manager of 23rd Century Capital LLC. Dr. Rothberg disclaims beneficial ownership of the shares held by these persons and entities except to the extent of his pecuniary interest therein.